Literature DB >> 11685489

Relationship between thallium-201 kinetics and proliferative activity assessed by monoclonal antibody MIB-1 in brain tumours.

K Motoyama1, K Suga, N Kume, A Hara, Y Ishikawa, N Matsunaga, T Nishizaki.   

Abstract

To clarify the relationship between thallium-201 chloride kinetics and proliferative activity in brain tumours. a single-photon emission tomographic (SPET) study was performed and the results correlated with monoclonal antibody MIB-1 staining of the tumour tissue. 201T1 SPET was performed 10 min (early scan) and 2 h (delayed scan) after intravenous administration of 201TI (111 MBq) in 34 intra-axial tumours including 24 malignant tumours, and in 27 extra-axial tumours including one malignant tumour. Tumour 201T1 kinetic parameters [early and delayed uptake ratios (ER and DR, respectively), retention index (RI), and the ratio of tumour delayed activity to early activity (Td/Te)] were compared with tumour tissue MIB-1 labelling indices (MIB-1 LI) representative of tumour cell proliferative activity. In the intra-axial tumours, ER and DR and MIB-1 LI were significantly higher in the malignant tumours than in the benign tumours. ER and DR were significantly correlated with MIB-1 LI (P<0.01 and P<0.05, respectively), but RI and Td/Te were not. In the extra-axial benign tumours, ER was as high as that in the intra-axial malignant tumours, while MIB-1 LI was equal to that in the intra-axial benign tumours. There were no significant correlations between any 201T1 kinetic parameters and MIB-1 LI. This study indicates that 201T1 ER may be the most reliable parameter for predicting the proliferative activity of intra-axial tumours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685489     DOI: 10.1007/s002590100587

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  1 in total

1.  Voxel-based analysis of (201)Tl SPECT for grading and diagnostic accuracy of gliomas: comparison with ROI analysis.

Authors:  Tomoyuki Kuwako; Sunao Mizumura; Ryusuke Murakami; Tamiko Yoshida; Masato Shiiba; Hidetaka Sato; Yoshimitsu Fukushima; Akira Teramoto; Shin-Ichiro Kumita
Journal:  Ann Nucl Med       Date:  2013-04-17       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.